We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

83 hedge funds and large institutions have $136M invested in Infinity Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

97% more capital invested

Capital invested by funds: $68.9M → $136M (+$66.9M)

51% more funds holding

Funds holding: 55 → 83 (+28)

7% less call options, than puts

Call options by funds: $1.66M | Put options by funds: $1.78M

Holders
83
Holders Change
+28
Holders Change %
+50.91%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
25
Reduced
9
Closed
9
Calls
$1.66M
Puts
$1.78M
Net Calls
-$124K
Net Calls Change
-$117K

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$21.9M
2
Millennium Management
Millennium Management
New York
+$7.81M
3
ACM
AIGH Capital Management
Maryland
+$5.51M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.05M
5
TLP
Tri Locum Partners
New York
+$4.04M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$30.2M
2
OM
Opaleye Management
Massachusetts
-$6.72M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.6M
4
BBA
Baker Bros. Advisors
New York
-$1.11M
5
EI
EAM Investors
California
-$893K
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
51
LMR Partners
United Kingdom
$99K +$102K +30,531 New
Charles Schwab
52
Charles Schwab
California
$97K – – –
HSBC Holdings
53
HSBC Holdings
United Kingdom
$69K +$70.6K +21,172 New
CAPTRUST Financial Advisors
54
CAPTRUST Financial Advisors
North Carolina
$63K +$65.1K +19,500 New
Bank of America
55
Bank of America
North Carolina
$57K +$55.1K +16,522 +1,502%
Balyasny Asset Management
56
Balyasny Asset Management
Illinois
$54K +$56.3K +16,873 New
Citigroup
57
Citigroup
New York
$48K +$49.1K +14,716 New
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$45K +$46.1K +13,820 +5,881%
JG
59
Jefferies Group
New York
$43.6K +$45K +13,500 New
Victory Capital Management
60
Victory Capital Management
Texas
$42K +$10.1K +3,040 +30%
Capstone Investment Advisors
61
Capstone Investment Advisors
New York
$41K -$115K -34,326 -73%
PAG
62
Private Advisor Group
New Jersey
$40K +$41.7K +12,500 New
APWA
63
Atlas Private Wealth Advisors
New Jersey
$39K +$40K +12,000 New
MML Investors Services
64
MML Investors Services
Massachusetts
$35K – – –
Janney Montgomery Scott
65
Janney Montgomery Scott
Pennsylvania
$32K +$33.4K +10,000 New
RTS
66
Round Table Services
New Jersey
$32K +$33.4K +10,000 New
Barclays
67
Barclays
United Kingdom
$30K +$30.8K +9,217 New
Wells Fargo
68
Wells Fargo
California
$29K +$447 +134 +2%
CB
69
Community Bank
New York
$19K -$20K -6,000 -50%
Federated Hermes
70
Federated Hermes
Pennsylvania
$7K +$4.83K +1,449 +184%
UBS Group
71
UBS Group
Switzerland
$6K +$2.69K +805 +71%
TCWM
72
Total Clarity Wealth Management
Illinois
$6K +$6.67K +2,000 New
GRP
73
Global Retirement Partners
California
$3K – – –
OSAM
74
O'Shaughnessy Asset Management
Connecticut
$3K +$1.61K +484 +155%
Osaic Holdings
75
Osaic Holdings
Arizona
$3K +$1.67K +500 +137%
1 2
3
4

INFI Hedge Fund Activity: Q1 2021 in Review

83 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2021, worth a combined $136M — up 97% from $68.9M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new INFI positions and 9 closed out — a net gain of 29 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $21.9M. The largest seller was BVF Inc, cutting an estimated $30.2M.

  • 83 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2021, up from 55 in Q4 2020.
  • Funds reported $136M of Infinity Pharmaceuticals, Inc. stock for Q1 2021, up 97% quarter-over-quarter.
  • 38 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2021 and 9 closed out, a net change of +29 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2021 was Consonance Capital Management, an estimated $21.9M added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q1 2021 was BVF Inc, an estimated $30.2M sold.

Based on aggregated 13F filings for Q1 2021.